Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine-free cigarettes plus nicotine replacement therapy for smoking cessation
ACTRN12608000410358Phase 4Completed
- Sponsor
- Health Research Council of New Zealand
- Start
- Apr 2009
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine patch and nicotine in nicotine dependence (2 arms), sponsored by Health Research Council of New Zealand. Primary endpoint: Seven-day point prevalence abstinence at 6 months. Started Apr 2009; status: completed.
02
Drugs
nicotine patchnicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12608000410358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000410358.